Trial
NCT06968195
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Advanced Hepatocellular Carcinoma
Intervention
Anti-GPC3-CAR Autologous T Lymphocytes
Why stopped
awaiting agreement with Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-22